These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10949204)

  • 21. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
    Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
    Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
    Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
    Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
    Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
    Frost AE; Quiñones MA; Zoghbi WA; Noon GP
    J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope.
    Sato A; Maie K; Ohno Y; Yoshida T; Ito E; Tanabe Y; Aizawa Y
    Int Heart J; 2011; 52(4):243-5. PubMed ID: 21828952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
    Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portopulmonary hypertension and hepatopulmonary syndrome: two different entities affecting pulmonary vasculature in liver disease.
    Martinez-Pallí G; Vidal JB; Beltrán J; Taurà P
    Crit Care Med; 2005 Jan; 33(1):269. PubMed ID: 15644703
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
    Weston MW; Isaac BF; Crain C
    J Heart Lung Transplant; 2001 Dec; 20(12):1340-4. PubMed ID: 11744420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
    Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Barry PW
    Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL; Melgosa MT; Burgos F; Valera JL; Pizarro S; Roca J; Rodriguez-Roisin R; Barberà JA
    Liver Transpl; 2007 Nov; 13(11):1506-14. PubMed ID: 17969197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.